CTI to market ETView Medical's VivaSight products in US

Jun 10 2013

ETView Medical Ltd. announced today that it has entered into an exclusive distribution agreement with Clinical Technologies, Inc. (CTI). The agreement allows CTI to market ETView's VivaSight™ products which combine airway ventilation tubes with integrated continuous high resolution airway imaging for patient airway management and lung isolation capability in the US states of North Dakota, South Dakota, Nebraska, Kansas, Missouri, Iowa, Minnesota, Wisconsin, Illinois, Kentucky, Indiana, Ohio, Michigan, and West Virginia for a period of two years; other terms were not disclosed.

“VivaSight™ products are distributed in Europe, Asia, and the United States. VivaSight™ provides best-in-class airway management solutions for sophisticated thoracic surgical procedures requiring lung isolation.”

William Edelman, CEO of ETView Medical commented, "We are excited to add Clinical Technologies to our expanding distributor network." Mr. Edelman continued, "VivaSight™ products are distributed in Europe, Asia, and the United States. VivaSight™ provides best-in-class airway management solutions for sophisticated thoracic surgical procedures requiring lung isolation."

On May 6, 2013, ETView Medical, Ltd. announced an exclusive distribution agreement with Mercury Medical, Inc. to market ETView's VivaSight™ products in Florida, Georgia, South Carolina, North Carolina, Virginia, Maryland, District of Columbia, Tennessee, Arkansas, Alabama, Mississippi, Louisiana, Texas, and Oklahoma.

On March 30, 2013, ETView Medical, Ltd. announced US FDA Clearance of a 510(k) Pre-marketing Notification Application expanding the VivaSight™-DL line of innovative airway devices.

On March 18, 2013, ETView Medical, Ltd. announced State Food and Drug Administration (SFDA, China) Clearance of a Pre-marketing Notification Application for the VivaSight™-SL line of innovative airway devices.